PM360 features Medocity while highlighting new solutions and strategies to improve medication adherence
PARSIPPANY, NJ – Medocity has been featured in the July 2019 edition of PM360 highlighting new ways to improve medication adherence. In the article, entitled New Adherence Solutions Worth Checking Out, PM360 introduces the emergence of innovative adherence solutions available to the Pharma industry and how new technologies and unique strategies are being applied.
The Medocity Enterprise Platform was covered in depth along with solutions from five other select companies researched and recommended in the article. Published monthly, PM360 magazine’s audience includes buyers, product managers and key decision makers in the pharmaceutical, biotech, and medical device industries.
Click here for original story.
Medocity Inc., headquartered in Parsippany, New Jersey, is a recognized leader in enterprise virtual care technology serving life sciences, payers and provider organizations seeking best-in-class digital solutions to improve outcomes and reduce healthcare costs between visits. Bridging the gap between the clinic and the home, the Medocity Virtual Care Platform enables optimized engagement and continuous care for patients with chronic and complex conditions. Medocity’s award-winning technology combines condition management, remote monitoring, artificial intelligence, cognitive computing, and telehealth interventions in a single cloud-based ecosystem. Accessible in real time on any device or operating system, the Medocity platform integrates with EMRs, digital assistants, and hundreds of connected sensors delivering meaningful patient-centered care outside traditional clinical settings. Virtual care. Real outcomes.™
For more information, please visit www.medocity.com.